X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60) 60
hematology (41) 41
index medicus (38) 38
female (33) 33
male (27) 27
adult (24) 24
middle aged (19) 19
platelet count (18) 18
transfusion (17) 17
abridged index medicus (12) 12
aged (12) 12
blood transfusion (11) 11
platelets (10) 10
purpura, thrombocytopenic, idiopathic - drug therapy (9) 9
thrombocytopenia (9) 9
treatment outcome (9) 9
adolescent (8) 8
medicine, general & internal (8) 8
oncology (8) 8
blood (7) 7
blood platelets (7) 7
leukocytes (7) 7
platelet transfusion - adverse effects (7) 7
purpura (7) 7
purpura, thrombocytopenic, idiopathic - blood (7) 7
splenectomy (7) 7
article (6) 6
blood platelets - immunology (6) 6
child, preschool (6) 6
double-blind method (6) 6
efficacy (6) 6
plasma (6) 6
platelet transfusion (6) 6
pregnancy (6) 6
purpura, thrombocytopenic, idiopathic - diagnosis (6) 6
risk (6) 6
surgery (6) 6
thrombopoietin (6) 6
transplantation (6) 6
adult patients (5) 5
adults (5) 5
analysis (5) 5
antibodies (5) 5
blood donors (5) 5
blood platelets - physiology (5) 5
cancer (5) 5
chemotherapy (5) 5
child (5) 5
leukemia (5) 5
management (5) 5
patients (5) 5
platelet transfusions (5) 5
pregnancy complications, hematologic - diagnosis (5) 5
purpura, thrombocytopenic, idiopathic - physiopathology (5) 5
purpura, thrombocytopenic, idiopathic - therapy (5) 5
quality-of-life (5) 5
retrospective studies (5) 5
young adult (5) 5
alloimmunization (4) 4
anemia (4) 4
anesthesiology (4) 4
autoantibodies (4) 4
care and treatment (4) 4
clinical trials (4) 4
delivery, obstetric (4) 4
hematology, oncology and palliative medicine (4) 4
hemorrhage - therapy (4) 4
high-dose dexamethasone (4) 4
irradiation (4) 4
medical research (4) 4
mortality (4) 4
purpura, thrombocytopenic, idiopathic - immunology (4) 4
randomized controlled-trial (4) 4
receptors, fc - administration & dosage (4) 4
safety (4) 4
severity of illness index (4) 4
storage (4) 4
thrombocytopenia - etiology (4) 4
thrombocytopenia - therapy (4) 4
thrombocytopenic purpura (4) 4
time factors (4) 4
usage (4) 4
women (4) 4
acute lung injury (3) 3
acute-leukemia (3) 3
aged, 80 and over (3) 3
alloantibodies (3) 3
anti-d (3) 3
anticoagulants - therapeutic use (3) 3
antigens (3) 3
apheresis (3) 3
bleeding (3) 3
blood component removal (3) 3
blood components (3) 3
blood preservation - methods (3) 3
blood transfusions (3) 3
cardiac-surgery (3) 3
cardiopulmonary bypass (3) 3
case-control studies (3) 3
cd4 lymphocyte count (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Oncologist, ISSN 1083-7159, 01/2009, Volume 14, Issue 1, pp. 12 - 21
The mechanism of idiopathic (autoimmune) thrombocytopenic purpura (ITP) has historically been attributed to platelet autoantibody production and the resultant... 
Thrombocytopenia | ITP | Platelets | Thrombopoietin | AUTOANTIBODIES | RECEPTOR | PLATELET PRODUCTION | C-MPL LIGAND | MEGAKARYOCYTE GROWTH | PLASMA | ONCOLOGY | KINETICS | ELTROMBOPAG | THROMBOPOIETIN LEVELS | T-CELLS | Blood Platelets - immunology | Purpura, Thrombocytopenic, Idiopathic - immunology | Humans | Purpura, Thrombocytopenic, Idiopathic - blood
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2016, Volume 2016, Issue 1, pp. 232 - 235
Journal Article
Lancet, The, ISSN 0140-6736, 02/2008, Volume 371, Issue 9610, pp. 395 - 403
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 38 - 47
A mild thrombocytopenia is relatively frequent during pregnancy and has generally no consequences for either the mother or the fetus. Although representing no... 
POSTPARTUM PLASMA-EXCHANGE | PLATELET COUNTS | VON-WILLEBRAND-DISEASE | IMMUNE THROMBOCYTOPENIA | OBSTETRIC PATIENTS | PURPURA | ACUTE FATTY LIVER | HELLP HEMOLYSIS | ELEVATED LIVER-ENZYMES | HEMATOLOGY | FACTOR-CLEAVING PROTEASE | HELLP Syndrome - drug therapy | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Hemolytic-Uremic Syndrome - blood | Plasma Exchange | Pregnancy Complications, Hematologic - drug therapy | Contraindications | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Young Adult | Purpura, Thrombocytopenic, Idiopathic - therapy | HELLP Syndrome - diagnosis | Thrombocytopenia - drug therapy | Purpura, Thrombotic Thrombocytopenic - drug therapy | Adult | Female | Hemolytic-Uremic Syndrome - therapy | Hemolytic-Uremic Syndrome - diagnosis | Infant, Newborn | Diagnosis, Differential | Antibodies, Monoclonal, Murine-Derived | Thrombocytopenia - etiology | HELLP Syndrome - blood | Purpura, Thrombotic Thrombocytopenic - congenital | Thrombocytopenia - congenital | Rituximab | Anticoagulants - therapeutic use | Combined Modality Therapy | Purpura, Thrombotic Thrombocytopenic - diagnosis | Anticoagulants - adverse effects | Purpura, Thrombotic Thrombocytopenic - prevention & control | Danazol | Algorithms | Purpura, Thrombocytopenic, Idiopathic - diagnosis | Pre-Eclampsia - blood | Immunosuppressive Agents - adverse effects | Thrombocytopenia - diagnosis | Disease Management | Pregnancy - blood | Purpura, Thrombotic Thrombocytopenic - blood | Fetal Monitoring
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2019, Volume 110, Issue 2, pp. 255 - 259
A proportion of patients with immune thrombocytopenic purpura are refractory to multiple therapies including thrombopoietin-receptor agonists (TPO-RA). We... 
Refractory | Medicine & Public Health | Hematology | Glucocorticoids | Thrombopoietin-receptor agonists | Oncology | Immune thrombocytopenic purpura | Autoimmune thrombocytopenia | CHRONIC IMMUNE THROMBOCYTOPENIA | EFFICACY | SAFETY | ROMIPLOSTIM | MECHANISMS | COMBINATION | THERAPY | PLATELETS | ELTROMBOPAG | HEMATOLOGY | LONG-TERM TREATMENT | Benzoates - adverse effects | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - pharmacology | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Child, Preschool | Male | Thrombopoietin - therapeutic use | Thrombopoietin - administration & dosage | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Adult | Female | Drug Therapy, Combination | Hydrazines - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Purpura, Thrombocytopenic, Idiopathic - surgery | Hydrazines - pharmacology | Hydrazines - therapeutic use | Prednisone - administration & dosage | Prednisone - adverse effects | Combined Modality Therapy | Thrombopoietin - pharmacology | Receptors, Thrombopoietin - antagonists & inhibitors | Benzoates - administration & dosage | Drug Synergism | Pyrazoles - administration & dosage | Platelet Count | Thrombopoietin - adverse effects | Receptors, Fc - administration & dosage | Adolescent | Benzoates - pharmacology | Prednisone - pharmacology | Aged | Prednisone - therapeutic use | Hydrazines - adverse effects | Prednisone | Corticosteroids | Research institutes | Thrombocytopenia | Thrombocytopenic purpura | Olefinic thermoplastic elastomers | Purpura | Patients | Thrombopoietin
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2012, Volume 2012, pp. 198 - 202
Thrombocytopenia is a common finding in pregnancy. Establishing the diagnosis of immune thrombocytopenia (ITP) in a pregnant patient is similar to doing so in... 
Diagnosis, Differential | Humans | Thrombocytopenia - immunology | Risk | Treatment Outcome | Obstetrics - methods | Pregnancy | Platelet Count | Immune System | Delivery, Obstetric | Adult | Female | Thrombocytopenia - diagnosis | Pregnancy Complications, Hematologic - diagnosis | Infant, Newborn
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2008, Volume 80, Issue 69, pp. 3 - 8
Immune thrombocytopenic purpura (ITP) is characterized by the presence of antiplatelet antibodies and immune platelet destruction. The disorder has been... 
platelet count | megakaryocytes | thrombocytopenic | idiopathic | purpura | thrombopoiesis | Thrombopoiesis | Megakaryocytes | Purpura | Platelet count | Thrombocytopenic | Idiopathic | AUTOANTIBODIES | SURVIVAL | DIAGNOSIS | ADULTS | MECHANISMS | PLATELET PRODUCTION | PREVALENCE | CHILDHOOD | HEMATOLOGY | EPITOPES | Thrombocytopenic purpura | Epidemiology
Journal Article
Hematology, ISSN 1520-4391, 2016, Volume 2016, Issue 1, pp. 232 - 235
Obstetrical hematology represents challenges not only for the patient, but also for her progeny. In particular, bleeding disorders, both congenital and... 
WOMEN | PRIMARY IMMUNE THROMBOCYTOPENIA | MATERNAL THROMBOCYTOPENIA | DIFFERENT FORMS | MANAGEMENT | VON-WILLEBRAND-DISEASE | COMPLICATIONS | HEMATOLOGY | EDUCATION, SCIENTIFIC DISCIPLINES | NEONATAL THROMBOCYTOPENIA | DEFICIENCY | HEMOPHILIA
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2010, Volume 362, Issue 7, pp. 600 - 613
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 12/2017, Volume 64, Issue 12, p. n/a
Journal Article
15.